Innovex Therapeutics

Innovex Therapeutics The new Spin-off is devoted to research, development, innovation, production, marketing and distribution of products related to the biotechnology sector.
(2)

INNOVEX THERAPEUTICS S.L. is the first Spanish company devoted to the valorization of Exosomes and Extracellular Vesicles as new platforms for vaccines and/or diagnostic tools. Cornerstone of the Spin-off is the discovery that reticulocyte-derived exosomes (rex) from malaria infections could be used as a new platform and vaccine against this disease. This approach is internationally protected (PC

T/EP2010/070800). is a brand new Spin-off co-founded by Hernando A del Portillo and Francesc E. Borrás, with 10% accionary participation of three Research Institutions:

icrea Institució Catalana de Recerca i Estudis Avançats

igtp Institut for Biomedical Research “Germans Trias i Pujol”

cresib The Barcelona Centre for International Health Research

Dirección

Badalona
08916

Página web

Notificaciones

Sé el primero en enterarse y déjanos enviarle un correo electrónico cuando Innovex Therapeutics publique noticias y promociones. Su dirección de correo electrónico no se utilizará para ningún otro fin, y puede darse de baja en cualquier momento.

Contacto La Empresa

Enviar un mensaje a Innovex Therapeutics:

Atajos

Compartir